Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.43 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | FBP1 | P09467 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.31 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.31 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.31 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.31 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5069345 | 1.00 | PDE4A (0.43) | PDE4AGRIK1LMNACYP1A2L3MBTL1 | |
| SCHEMBL1373854 | 0.88 | GRIK1 (0.44) | GRIK1CYP1A2CYP2C9TRPA1FBP1 | |
| SCHEMBL20506873 | 0.88 | GRIK1 (0.44) | GRIK1CYP1A2CYP2C9TRPA1FBP1 | |
| SCHEMBL28654643 | 0.85 | PDE4A (0.40) | PDE4ALMNAL3MBTL1TDP1ALDH1A1 | |
| SCHEMBL448867 | 0.85 | PDE4A (0.42) | PDE4ALMNAL3MBTL1TDP1CYP2C9 | |
| Benzene SCHEMBL28171160 | 0.85 | PDE4A (0.42) | PDE4ALMNAL3MBTL1TDP1CYP2C9 | |
| Mannitol SCHEMBL27796662 | 0.85 | PDE4A (0.42) | PDE4ALMNAL3MBTL1TDP1CYP2C9 | |
| SCHEMBL5026236 | 0.85 | PDE4A (0.42) | PDE4ALMNAL3MBTL1TDP1CYP2C9 | |
| SCHEMBL20945396 | 0.85 | PDE4A (0.42) | PDE4ALMNAL3MBTL1TDP1CYP2C9 | |
| SCHEMBL6049014 | 0.84 | KDM4E (0.38) | PDE4AGRIK1LMNAL3MBTL1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3498713-B1 | TRANSPARENT NUCLEATING AGENT COMPOSITION COMPRISING SORBITOL TRIACETALS AND MONOACETALS | GCH TECH CO LTD (CN) | 2022-01-05 | — | — | EP | disclosed |
| CN-106715556-B | Granular nucleating agent and preparation method thereof | 呈和科技股份有限公司 | 2020-10-09 | — | — | CN | disclosed |
| EP-3498713-A1 | TRANSPARENT NUCLEATING AGENT COMPOSITION COMPRISING SORBITOL TRIACETALS AND MONOACETALS | GCH Technology Co., Ltd. (CN) | 2019-06-19 | — | — | EP | disclosed |
| US-10208057-B2 | Nucleator composition comprising sorbitol acetal, sorbitol diacetal and sorbitol triacetal | GCH TECHNOLOGY CO., LTD. (CN) | 2019-02-19 | — | — | US | disclosed |
| US-20180273545-A1 | NUCLEATOR COMPOSITION COMPRISING SORBITOL ACETAL, SORBITOL DIACETAL AND SORBITOL TRIACETAL | GCH TECHNOLOGY CO., LTD. (CN) | 2018-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180273545-A1 | NUCLEATOR COMPOSITION COMPRISING SORBITOL ACETAL, SORBITOL DIACETAL AND SORBITOL TRIACETAL | SORD, DERA, SMCHD1 | PDE4A 1881/4885GRIK1 4246/4885LMNA 1274/4885 |
| US-10208057-B2 | Nucleator composition comprising sorbitol acetal, sorbitol diacetal and sorbitol triacetal | SORD, DERA, SMCHD1 | PDE4A 1937/4885GRIK1 4155/4885LMNA 749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.